NOW members call for FDA approval of Mifepristone (RU-486) for abortion, cancer and other treatments

Article Abstract:

This article discusses the National Organization for Women (NOW)'s lobbying efforts for the quick and unrestricted approval of mifepristone (RU-486) by the Food and Drug Administration. The anti-progesterone drug blocks hormones needed to maintain pregnancy and provides a safe and effective alternative to surgical abortions and can also be used to treat Cushings Syndrome, menegiomas and breast cancer when used with tamoxifen; it is used effectively in 14 other countries but is opposed by anti-abortionists in the United States.

Management, Planning, Drug therapy, Breast cancer, Abortion, United States. Food and Drug Administration, Mifepristone

---

NOW, Nadler unite against 'honor killing'

Article Abstract:

This article discusses a resolution developed by the National Organization for Women (NOW) and Representative Jerrold Nadler of New York that would call for the inclusion of honor-crimes in the State Department's annual report on human rights. Honor killings are crimes committed against female family members for allegedly disgracing their families, and which are monitored by Amnesty International and other human rights groups.

Laws, regulations and rules, Reports, Women, Crimes against, Women's rights, United States. Department of State, Family violence, Domestic violence, Amnesty International, Nadler, Jerrold

---

NOW advocates for more diverse representation in U.S. government

Article Abstract:

The National Organization of Women is advocating that the United States move to an proportional representation system that would create more diversity in federal, state and local governments. The system would call for larger districts with multiple representatives that would include multiple winners in each race.

Statistics, Political aspects, Women politicians, Minority politicians, Proportional representation

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.